Clinical and Economic Outcomes of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Post-Bundling Era

RATIONALE & OBJECTIVE: Since the change in erythropoiesis-stimulating agent (ESA) labeling and bundling of dialysis services in the United States, few studies have addressed the clinical importance of ESA hyporesponsiveness and none have considered health care resource use in this population. We...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Kidney Med
Egile Nagusiak: Cizman, Borut, Smith, Helen T., Camejo, Rodrigo Refoios, Casillas, Linda, Dhillon, Harjeet, Mu, Fan, Wu, Eric, Xie, Jipan, Zuckerman, Peter, Coyne, Daniel
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2020
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7568064/
https://ncbi.nlm.nih.gov/pubmed/33089137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xkme.2020.06.008
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak